{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:03:24Z","timestamp":1753891404884,"version":"3.41.2"},"reference-count":5,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T00:00:00Z","timestamp":1676937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"DOI":"10.3389\/fmolb.2023.1150641","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T09:01:39Z","timestamp":1676970099000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Editorial: Cancer diagnostics in solid tumors-from pathology to precision oncology"],"prefix":"10.3389","volume":"10","author":[{"given":"Umberto","family":"Malapelle","sequence":"first","affiliation":[]},{"given":"Pedro","family":"Borralho","sequence":"additional","affiliation":[]},{"given":"Liang","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Fernando","family":"Schmitt","sequence":"additional","affiliation":[]}],"member":"1965","published-online":{"date-parts":[[2023,2,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/nrclinonc.2011.121","article-title":"Predictive biomarkers: A paradigm shift towards personalized cancer medicine","volume":"8","author":"La Thangue","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"103776","DOI":"10.1016\/j.critrevonc.2022.103776","article-title":"The evolving landscape of anatomic pathology","volume":"178","author":"Pisapia","year":"2022","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"788690","DOI":"10.3389\/fmolb.2021.788690","article-title":"MicroRNA-125b-5p correlates with prognosis and lung adenocarcinoma progression","volume":"8","author":"Tang","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"901829","DOI":"10.3389\/fmolb.2022.901829","article-title":"DNA damage response gene-based subtypes associated with clinical outcomes in early-stage lung adenocarcinoma","volume":"9","author":"Zhao","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1030057","DOI":"10.3389\/fmolb.2022.1030057","article-title":"TSPAN4 is a prognostic and immune target in Glioblastoma multiforme","volume":"9","author":"Zheng","year":"2023","journal-title":"Front. Mol. Biosci."}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2023.1150641\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T09:01:40Z","timestamp":1676970100000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2023.1150641\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,21]]},"references-count":5,"alternative-id":["10.3389\/fmolb.2023.1150641"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2023.1150641","relation":{},"ISSN":["2296-889X"],"issn-type":[{"type":"electronic","value":"2296-889X"}],"subject":[],"published":{"date-parts":[[2023,2,21]]},"article-number":"1150641"}}